Acute Myeloid Leukaemia: New Targets and Therapies
By Geoffrey Brown, E. Marcinkowska. International Journal of Molecular Sciences, 2017
695 citations recorded by the source corpus.
The most common acute hematological malignancy in adults is acute myeloid leukaemia (AML), accounting for more than 80% of cases in patients over 60 years of age [...].
Subfields: Hematology, Molecular Biology, Orthopedics and Sports Medicine
View Paper: https://www.semanticscholar.org/paper/1c9d069b01fc267835dcfe8f2bb9c1782fd0e616
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hematology
Citations in the corpus
- Acute myeloid leukemia: current progress and future directions (2021, methodology): “(2) Optimization of the dose of daunorubicin (60mg/m(2) daily × 3, versus 45mg/m(2) or 90mg/m(2) daily × 3) and the use of other anthracyclines (idarubicin, mitoxantrone).”